Product Code: 5169
The compartment syndrome monitoring devices market is projected to witness massive growth by 2030 due to high prevalence of compartment syndrome and intra-abdominal hypertension (IAH). In addition, rapid R&D in the field of monitoring devices is also likely to boost market growth over the forecast period.
During the initial phase of the COVID-19 outbreak, the industry witnessed remarkable growth owing to rising instances of trauma in coronavirus-infected patients. Hospitals observed a hike in compartment syndrome, thereby propelling product demand.
Moreover, major industry players have been focusing on product advancements and strategic partnerships & mergers to improve their presence in the competitive landscape. For instance, in October 2021, MY01, Inc., a medical device company, received breakthrough device designation by FDA for its MY01 continuous compartment pressure monitor that enables full Bluetooth capabilities to effectively treat or manage compartment syndrome.
To cite another instance, in March 2022, C2Dx, another industry leader, announced the acquisition of Hemostatix Medical Technologies LLC, a medical device specialist. The acquisition complemented C2Dx's plans to enhance the delivery of niche medical products around the world.
The compartment syndrome monitoring devices market has been bifurcated on the basis of end-use, product, syndrome type, and region.
In terms of product, the compartment syndrome monitoring devices industry has been split into equipment and disposables. The disposables segment held a significant market share in 2021 with a valuation of around $44 million and is set to exhibit robust growth over 2022-2030. Novel advancements in devices are expected to drive segmental adoption through the analysis period.
With regards to syndrome type, the industry has been divided into abdominal compartment syndrome, chronic compartment syndrome, and acute compartment syndrome. In 2021, the compartment syndrome monitoring devices market share from the abdominal compartment syndrome segment was valued at over $60 million and is slated to progress with a considerable growth rate over the review timespan due to soaring prevalence of IAH and abdominal compartment syndrome.
The compartment syndrome monitoring devices industry has been segregated from the end-use perspective into clinics, hospitals, and others. The hospitals segment is poised to reach around $161 million in revenue by the end of 2030. Growing incidences of compartment syndrome among high-risk patients seeking treatment at emergency and intensive care units in hospitals are anticipated to accelerate segmental growth.
In the regional framework, the Latin America compartment syndrome monitoring devices market recorded a valuation of more than $10 million in 2021 and is estimated to exhibit remarkable growth through the assessment timeline. Surging occurrences of compartment syndrome, IAH, and increasing product adoption across the region are speculated to bolster market uptake in LATAM in the coming years.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definition
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Compartment syndrome monitoring devices industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Syndrome type trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Compartment Syndrome Monitoring Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030 (USD Million)
- 3.3 Industry impact factors
- 3.3.1 Growth drivers
- 3.3.1.1 Rising prevalence of trauma cases, sports injuries, and other chronic diseases
- 3.3.1.2 Technological advancements
- 3.3.1.3 Growing prevalence of intra-abdominal hypertension
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Lack of accurate diagnostics
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By syndrome type
- 3.4.3 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Compartment syndrome landscape
- 3.6.1 Overview
- 3.6.2 Legal costs
- 3.6.3 Financial costs
- 3.7 Regulatory landscape
- 3.8 Porter's analysis
- 3.9 Competitive landscape, 2021
- 3.9.1 Company matrix analysis, 2021
- 3.10 PESTEL analysis
Chapter 4 Compartment Syndrome Monitoring Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Disposables
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Equipment
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Compartment Syndrome Monitoring Devices Market, By Syndrome type
- 5.1 Key segment trends
- 5.2 Acute compartment syndrome
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Chronic compartment syndrome
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Abdominal compartment syndrome
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Compartment Syndrome Monitoring Devices Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Clinics
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Others
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Compartment Syndrome Monitoring Devices Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.5.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.5.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7 France
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8 Spain
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9 Italy
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5 China
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.5.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.6 Japan
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.5.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.7 Argentina
- 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.7.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6 Middle East and Africa
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.5.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.7 UAE
- 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.7.2 Market size, by syndrome type, 2017 - 2030 (USD Million)
- 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2021
- 8.2 Millar, Inc.
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Medline Industries, Inc.
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 Becton, Dickenson, and Company
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 MY01, Inc.
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Critical Care Diagnostics (C2Dx), Inc.
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 Potrero Medical
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
- 8.8 ConvaTec Group
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
- 8.9 Biometrix Ltd. (3i Group plc)
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
- 8.10 Spiegelberg GmbH & Co. KG
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis